Recommendations for third COVID-19 vaccines in kidney patients

Clarification on kidney patients who are eligible for the third primary COVID-19 vaccination is now available.

 

The UK Kidney Association has reviewed the JCVI guideline and is recommending the use of a third primary COVID-19 vaccine in the following kidney patients:

 

  1. All kidney patients who have a transplant, including those who have returned to dialysis but still receive or have received immunosuppression in the last 6 months.

  2. All patients on the transplant waiting list.

  3. All patients on dialysis.

  4. Patients who at the time of the original second vaccine programme were receiving significant immunosuppression – these patients are defined further in the recommendations

 

The UKKA recommends that all kidney patients receiving a third primary vaccine dose should receive an mRNA vaccine as laboratory studies indicate these offer better protection in these kidney patients.

 

Read the full recommendations and supporting evidence 

Download template letters for corresponding with patients

 

Please note that this is not the same as the booster doses and may take some time to roll out.

 

The third primary COVID-19 dose will rely on Renal Units to identify those who are eligible but it will give patients access to the third primary dose as quickly as possible.

 

The dose can be given by either the hospital hub or via the GP after identification by the specialist. These patients will also be eligible for a separate booster dose at a later stage.

 

Guidelines

NICE accredited clinical practice guidelines 

Available here

23rd Annual Report

Analyses about the care provided to patients at UK renal centres.

Read the report

UKRR AKI Report

A report on the nationwide collection of AKI warning test scores. 

Read the report